Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders

Fertility and Sterility

Volumn 88, Issue 3, 2007, Pages 665-669

  Berkkanoglu, Murat ^a   Isikoglu, Mete ^a   Aydin, Donay ^a   Ozgur, Kemal ^a  

^a Antalya In Vitro Fertilization   (Turkey)

Author keywords

FSH; LH; microdose cycle; pregnancy rate; Recombinant hCG

Indexed keywords

ESTRADIOL; ETHINYLESTRADIOL PLUS GESTODENE; LEUPRORELIN; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FETUS HEART RATE; FOLLICULAR PHASE; HORMONAL THERAPY; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MENSTRUAL CYCLE; METAPHASE; OOCYTE DONATION; OVULATION INDUCTION; PREGNANCY RATE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

CHORIONIC GONADOTROPIN; DRUG THERAPY, COMBINATION; FEMALE; FOLLICLE STIMULATING HORMONE; FOLLICULAR PHASE; HUMANS; LUTEINIZING HORMONE; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS;

EID: 34548382970     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.11.150     Document Type: Article

References (33)

1. Loverro G., Nappi L., Mei L., Giaccomoantonio L., Carriero C., and Tartagni M. Evaluation of functional ovarian reserve in 60 patients. Reprod Biomed Online 7 (2003) 200-204
2. Garcia J., Padilla S., Bayati J., and Baramki T. Follicular phase gonadotropin-releasing hormone agonist and human menopausal gonadotropins: a better alternative for ovulation induction in in vitro fertilization. Fertil Steril 53 (1990) 302-305
3. Padilla S.L., Dugan K., Maruschak V., Shalika S., and Smith R.D. Use of the flare-up protocol with high dose human follicle-stimulating hormone and human menopausal gonadotropins for in vitro fertilization in poor responders. Fertil Steril 65 (1996) 796-799
4. Leondires M.P., Escalpes M., Segars J.H., Scott R.T., and Miller B.T. Microdose follicular phase gonadotropin-releasing hormone agonists (GnRH-a) compared with luteal phase GnRH-a for ovarian stimulation at in vitro fertilization. Fertil Steril 72 (1999) 1018-1023
5. Al-Inany H., Aboulghar M.A., Mansour R.T., and Proctor M. Recombinant versus urinary gonadotrophins for triggering ovulation in assisted conception. Hum Reprod 20 (2005) 2061-2073
6. Ben Rafael Z., Benadiva C., Ausmanas M., Barber B., Blasco L., Flickinger G., et al. Dose of human menopausal gonadotropin influences the outcome of an in vitro fertilization program. Fertil Steril 48 (1987) 964-968
7. Hofmann G., Toner J., Muasher S., and Jones G. High-dose follicle stimulating hormone (FSH) ovarian stimulation in low responder patients for in vitro fertilization. J In Vitro Fert Embryo Trans 6 (1993) 285-289
8. Surrey E.S., Boer J., Hill D.M., Ramsey J., and Surey M.W. Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization. Fertil Steril 69 (1998) 419-424
9. Stokman P.G., de Leeuw R., van den Wijngaard H.A., Kloosterboer H.J., Vemer H.M., and Sanders A.L. Human chorionic gonadotropin in commercial human menopausal gonadotropin preparations. Fertil Steril 60 (1993) 175-178
10. Filicori M., Cognigni G.E., Tabarelli C., Pocognoli P., Taraborrelli S., Spettoli D., and Ciampaglia W. Stimulation and growth of antral ovarian follicles by selective LH activity administration in women. J Clin Endocrinol Metab 87 (2002) 1156-1161
11. Kelly E.E., and Nebiolo L. Recombinant FSH therapy alone versus combination therapy with recombinant LH therapy in patients down-regulated with a low dose luteal GnRH agonist protocol: preliminary results. In: Jansen R., Mortimer D., and Coote K. (Eds). Towards reproductive certainty: fertility and genetics beyond (1999), Parthenon, Carnforth, Lancashire, UK 200-204
12. Lloyd A., Phil M., Kennedy R., Hutchinson J., and Sawyer W. Economic evaluation of highly purified menotropin compared with recombinant follicle-stimulating hormone in assisted reproduction. Fertil Steril 80 (2003) 1108-1113
13. Perin P.M., Maluf M., Czeresnia C.E., and Sousa P.D. The effect of recombinant human luteinizing hormone on oocyte/embryo quality and treatment outcome in down-regulated women undergoing in vitro fertilization. Fertil Steril 80 Suppl 3 (2003) S76-S77
14. Commenges-Ducos M., Piault S., Papaxanthos A., Ribes C., Dallay D., and Commenges D. Recombinant follicle-stimulating hormone versus human menopausal gonadotropin in the late follicular phase during ovarian hyperstimulation for in vitro fertilization. Fertil Steril 78 (2002) 1049-1054
15. Gordon U., Harrison R.F., Fawzy M., Hennelly B., and Gordon A.C. A randomized prospective assessor-blind evaluation of luteinizing hormone dosage and in vitro fertilization outcome. Fertil Steril 75 (2001) 324-331
16. Filicori M. The role of luteinizing hormone in folliculogenesis and ovulation induction. Fertil Steril 71 (1999) 405-414
17. Filicori M., Cognigni G.E., Taraborelli S., Spettoli D., Ciampaglia W., Tabarelli De Fatis C., Pocognoli P., Cantelli B., and Boschi S. Luteinizing hormone activity in menotropins optimizes folliculogenesis and treatment in controlled ovarian stimulation. J Clin Endocrinol Metab 86 (2001) 337-343
18. Balasch J., Fabregues F., Creus M., Moreno V., Peurto B., Penarrubia J., et al. Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in vitro fertilization. Hum Reprod 11 (1996) 2400-2404
19. Imthurn B., Macas E., Roselli M., and Keller P.J. Nuclear maturity and oocyte morphology after stimulation with highly purified follicle stimulating hormone compared to human menopausal gonadotrophin. Hum Reprod 11 (1996) 2387-2391
20. Esposito M.A., Barnhart K.T., Coutifaris C., and Patrizio P. Role of periovulatory luteinizing hormone concentrations during assisted reproductive technology cycles stimulated exclusively with recombinant follicle-stimulating hormone. Fertil Steril 75 (2001) 519-524
21. Westergaard L.G., Laursen S.B., and Andersen C.Y. Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotropic women undergoing assisted reproduction. Hum Reprod 15 (2000) 1003-1008
22. Marrs R., Meldrum D., Muasher S., Schoolcraft W., Werlin L., and Kelly E. Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment. Reprod Biomed Online 8 (2003) 175-182
23. Lisi F., Rinaldi L., Fishel S., Lisi R., Pepe G., and Picconeri M.G. Use of recombinant follicle-stimulating hormone (Gonal F) and recombinant luteinizing hormone (Luveris) for multiple follicular stimulation in patients with a suboptimal response to in vitro fertilization. Fertil Steril 79 (2003) 1037-1038
24. Ferrari B., Barusi L., and Coppola F. Clinical and endocrine effects of ovulation induction with FSH and hCG supplementation in low responders in the midfollicular phase. A pilot study. J Reprod Med 47 (2002) 137-143
25. Tarlatzis B., Tavmergen E., Szamatowicz M., Barash A., Amit A., Levitas E., and Shoham Z. The use of recombinant human LH (lutropin alfa) in the late stimulation phase of assisted reproduction cycles: a double-blind, randomized, prospective study. Hum Reprod 21 (2006) 90-94
26. Griesinger G., Schultze-Mosgau A., Dafopoulos K., Schroeder A., Schroer A., von Otte S., et al. Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol. Hum Reprod 20 (2005) 1200-1206
27. Mercan R., Mayer J.F., Walker D., Jones S., Oehninger S., Toner J.P., and Muasher S.J. Improved oocyte quality is obtained with follicle stimulating hormone/human menopausal gonadotrophin combination. Hum Reprod 12 (1997) 1886-1889
28. Balasch J., Creus M., Fabregues F., Civico S., Carmona F., Puerto B., et al. The effect of exogenous luteinizing hormone (LH) on oocyte viability: evidence from a comparative study using recombinant human follicle-stimulating hormone (FSH) alone or in combination with recombinant LH for ovarian stimulation in pituitary-suppressed women undergoing assisted reproduction. J Assist Reprod Genet 18 (2001) 250-256
29. Weissman A., Meriano J., Ward S., Gotlieb L., and Casper R.F. Intracytoplasmic sperm injection after follicle stimulation with highly purified human follicle-stimulating hormone compared with human menopausal gonadotropin. J Assist Reprod Genet 16 (1999) 63-68
30. Ng E.H., Lau E.Y., Yeung W.S., and Ho P.C. HMG is as good as recombinant human FSH in terms of oocyte and embryo quality: a prospective randomized trial. Hum Reprod 16 (2001) 319-325
31. Filicori M., Cognigni G.E., Pocognoli P., Tabarelli C., Spettoli D., Taraborelli S., and Ciampaglia W. Modulation of folliculogenesis and steroidogenesis in women by graded menotropin administration. Hum Reprod 17 (2002) 2009-2015
32. Filicori M., Cognigni G.E., Taraborelli S., Spettoli D., Ciampaglia W., Tabarelli F., and Pocognoli P. Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome. J Clin Endocrinol Metab 84 (1999) 2659-2663
33. Filicori M. Clinical review 81: Gonadotropin-releasing hormone analogs in ovulation induction: current status and perspectives. J Clin Endocrinol Metab 81 (1996) 2413-2416